Cytosorbents Crp (CTSO)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $15.28M
Last updated: Nov 17, 2026 at 4:10 PM ET
Cytosorbents Crp (CTSO) Stock Chart
Cytosorbents Crp (CTSO) has a latest price of $4.52 on Nov 17, 2026, 73.4% below its 52-week high of $17.00. Its price fell 65.8% over the past 12 months. The month-end price fell 96.2% over the 10 years through Oct 2026, a compound annual decline of 27.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $293.00 in Aug 2018 and its lowest $3.90 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CTSO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CTSO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 36.5%, and over 6 months it fell 52.2%. The month-end price fell 85.3% over the 3 years through Oct 2026, a compound annual decline of 47.2%.
| Period | Change |
|---|---|
| 1 month | -8.9% |
| 3 months | -36.5% |
| 6 months | -52.2% |
| 12 months | -65.8% |
| 12 months, with dividends | -65.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -85.3% | -47.2% |
| 5 years | -96.1% | -47.9% |
| 10 years | -96.2% | -27.8% |
Price by Year
Its best calendar year was 2020, when the price rose 107.0%, and its weakest was 2022, when it fell 63.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.54 | -64.5% |
| 2025 | $12.78 | -29.8% |
| 2024 | $18.20 | -18.0% |
| 2023 | $22.20 | -28.4% |
| 2022 | $31.00 | -63.0% |
| 2021 | $83.80 | -47.4% |
| 2020 | $159.40 | +107.0% |
| 2019 | $77.00 | -52.4% |
| 2018 | $161.60 | +24.3% |
| 2017 | $130.00 | +19.3% |
Trading Range
The price is 5.6% below its 50-day average of $4.79 and 49.7% below its 200-day average of $8.98.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.52 | |
| 52-week high | $17.00 | -73.4% |
| 52-week low | $2.84 | +59.2% |
| 50-day average | $4.79 | -5.6% |
| 200-day average | $8.98 | -49.7% |
Price Risk
Over 3 years, its largest fall from a peak was 91.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.19 |
| Largest fall, 1 year | -81.7% |
| Largest fall, 3 years | -91.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CTSO
What is CTSO's 1-year price change?
Cytosorbents Crp's price fell 65.8% over the past 12 months. With dividends included, the 12-month total return was -65.8%.
What is CTSO's 5-year price change?
Cytosorbents Crp's month-end price fell 96.1% over the 5 years through Oct 2026, a compound annual decline of 47.9%. These figures leave out dividends.
What is CTSO's 52-week high and low?
Cytosorbents Crp's 52-week high is $17.00 and its 52-week low is $2.84. Its latest price of $4.52 on Nov 17, 2026 is 73.4% below the high.
What is CTSO's beta?
Cytosorbents Crp's 1-year beta against the S&P 500 is 1.19, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 81.7%.
Is the CTSO chart free?
Yes. Advanced Charting for CTSO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CTSO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors